Sudarshan Pharma Industries Ltd (SUDARSHAN) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Sudarshan Pharma Industries Ltd stock ₹20.15, price ₹31.26, that is 35.5% below the price, quality 38 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Sudarshan Pharma Industries Ltd
SUDARSHAN · BSEFar too expensive (fair value 36% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
44‑month range ₹5.10 – ₹51.83 · fair‑value band ₹12.72 – ₹25.18 · the ₹31.26 price screens above the ₹20.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Sudarshan Pharma Industries is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Sudarshan Pharma Industries Limited manufactures and sells specialty chemicals and intermediates for pharma, agro chemicals, coating, and various other industries in India. The company also focuses on manufactures active pharmaceuticals ingredients and vitamins manufacturing.
Show moreShow less
It also offers fine chemicals, solvents, agro chemicals, finish lubricants, inks, food colors, leather chemicals, oil field chemicals, lubricant specialties, paints and coatings, paper chemicals, personal and community hygiene products, pigments, polymers and additives, press room chemicals, sugar chemicals, textile chemicals, water treatment chemicals, rust preventives, metalworking fluids, PU additives, and other specialty chemicals.
In addition, the company offers antibiotics, antifungal, anthelmintic medications, antihypertensive, anti-diabetic drugs, analgesics, neurotonics, antihistamines, and cough syrups, as well as manufactures and supplies chemicals and solvents.
Further, it engages in the contract manufacturing and outsourcing and supply of generic pharma formulation and medicines to healthcare institution, government, NGO, and hospitals.
The company also exports its products to the United Kingdom, Australia, Uzbekistan, Syria, Oman, Taiwan, the Middle East, and North Africa regions. Sudarshan Pharma Industries Limited was incorporated in 2008 and is headquartered in Mumbai, India.
Stock analysis
Sudarshan Pharma Industries Ltd (SUDARSHAN) currently trades at ₹31.26, while our model-based Fair Value estimate is ₹20.15, 36% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹22.83 per share, and 1 of the 14 models we run sit above the ₹31.26 price.
Bear case: the Economic Profit group reads lowest at ₹8.34, and 13 of the 14 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹12.72 (bear) to ₹25.18 (bull), the price of ₹31.26 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Sudarshan Pharma Industries Ltd reported revenue of ₹7.0B in FY2026 versus ₹3.6B in FY2022, a compound +18.5%/yr. Reported net income was ₹233M in FY2026, compounding +45.2%/yr from FY2022.
Key figures
Market cap ₹8.9B (≈ $95.0M) Micro · P/E ratio 30.1 · P/S ratio 1.21 · EPS (TTM) ₹1.04 · Net margin 3.4% · Return on equity 16.2% · Return on assets (EBIT) 7.5% (5-year average) · Operating margin 8.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).
What moves the price
The share trades about 26% below its 52-week high and 63% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −24% fair-value upside, at −36%, SUDARSHAN screens richer than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
SUDARSHAN screens overvalued: fair value 36% below the price. Compare with BASF SE →
Compare Sudarshan Pharma Industries Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 360 stocks
Valuation Multiplesvs Chemicals median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| LG Chem, Ltd 051910 | 209,500 KRW | 587,755 KRW | +181% | vs SUDARSHAN |
| Dow Inc DOW | $30.37 | $41.88 | +38% | vs SUDARSHAN |
| Hengli Petrochemical Co 600346 | ¥16.05 | ¥19.26 | +20% | vs SUDARSHAN |
| Ningxia Baofeng Energy Group 600989 | ¥20.29 | ¥22.31 | +10% | vs SUDARSHAN |
| BASF SE BAS | €50.68 | €38.46 | −24% | vs SUDARSHAN |
| Zhejiang Juhua Co 600160 | ¥29.47 | ¥19.27 | −35% | vs SUDARSHAN |
| Jiangsu Eastern Shenghong Co 000301 | ¥9.80 | ¥6.28 | −36% | vs SUDARSHAN |
| Formosa Chemicals & Fibre Corporation 1326 | 62.70 TWD | 35.56 TWD | −43% | vs SUDARSHAN |
| Rongsheng Petrochemical Co 002493 | ¥10.92 | ¥4.15 | −62% | vs SUDARSHAN |
| Zangge Mining Company 000408 | ¥62.97 | ¥17.47 | −72% | vs SUDARSHAN |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Sudarshan Pharma Industries Ltd (SUDARSHAN) overvalued or undervalued?
What is the fair value of SUDARSHAN?
What is the quality score of SUDARSHAN?
What is the price target for Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the Sudarshan Pharma Industries Ltd stock forecast for 2026?
What is the revenue of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the intrinsic value of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
Is Sudarshan Pharma Industries Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SUDARSHAN?
How much is Sudarshan Pharma Industries Ltd worth?
What do the bullish and bearish scenarios say about SUDARSHAN?
What is the P/E ratio of SUDARSHAN?
How solid is the balance sheet of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
How far is SUDARSHAN from its 52-week high?
Which stocks are comparable to Sudarshan Pharma Industries Ltd?
Is Sudarshan Pharma Industries Ltd stock attractive at the current price?
How is the fair value of SUDARSHAN calculated?
Is it still worth investing in stocks now?
What is the share price of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What should I pay attention to with Sudarshan Pharma Industries Ltd right now?
Key figures of Sudarshan Pharma Industries Ltd
How large is the market capitalisation of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the P/S ratio of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What are the earnings per share of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the net margin of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the return on equity of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the EBIT return on assets of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
What is the operating margin of Sudarshan Pharma Industries Ltd (SUDARSHAN)?
How fast is revenue growing at Sudarshan Pharma Industries Ltd (SUDARSHAN)?
How fast are earnings growing at Sudarshan Pharma Industries Ltd (SUDARSHAN)?
How much free cash flow does Sudarshan Pharma Industries Ltd (SUDARSHAN) generate?
How much net debt does Sudarshan Pharma Industries Ltd (SUDARSHAN) carry?
Watch Sudarshan Pharma Industries Ltd in the live analysis
One click puts Sudarshan Pharma Industries Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.